학술논문

Results of a phase 2 trial of an oral CXCR4 antagonist, mavorixafor, for treatment of WHIM syndrome
Document Type
Article
Source
In Blood 24 December 2020 136(26):2994-3003
Subject
Language
ISSN
0006-4971